PrediSurge and Incepto Join Forces to Integrate AI based vascular intervention planning solutions into Clinical Workflows

France — PrediSurge is pleased to announce its collaboration with Incepto, a leading medical AI integration platform. Together, the two companies are bridging the gap between advanced artificial intelligence and everyday clinical practice, making AI-based EVAR planning a natural part of physicians’ existing workflows.

Bringing AI Where It Matters Most

One of the persistent challenges in clinical AI adoption is integration: even the most sophisticated algorithms are under utilised when they sit outside the natural flow of a physician’s day. This collaboration directly addresses that barrier. Through Incepto's orchestration and interoperability technology, hospitals can now connect their existing PACS systems to PrediSurge’s AI solutions without disrupting established workflows, removing the technical friction.

Direct Access to PlanOp.ai via the Incepto Platform

At the heart of this integration is PlanOp.ai, PrediSurge’s platform for advanced EVAR planning and AI-driven clinical decision support. Clinicians can now access PlanOp.ai directly through Incepto platform, benefiting from:

• Direct access to PrediSurge AI-powered solutions from the Incepto platform
• A streamlined transition from raw imaging data to patient-specific, actionable insights
• Deep integration into daily clinical workflows within PACS environments

Voices from collaboration

"PrediSurge has always built for the clinical reality, not around it. Our planning intelligence is designed to meet the physician inside the workflow, not beside it. With Incepto, we extend that reach to more hospitals, faster, through an integration channel that already lives inside their PACS. The conviction is ours. The reach is now shared.” - Bruno Virieux, CEO, PrediSurge.

"Integrating PrediSurge’s PlanOp.ai platform into our ecosystem is a natural extension of our commitment to the vascular surgery community, a journey we proudly began years ago with our ARVA application. By combining our orchestration technology with their advanced planning tools, we are giving specialists a seamless, comprehensive workflow integrated in their PACS environment." - Dr Gaspard d'Assignies, Co-Founder, CMO and Radiologist at Incepto Medical

A Shared Vision for Clinical AI

Both PrediSurge and Incepto share a fundamental conviction: AI in medicine must support clinical expertise rather than add complexity. This collaboration marks another step toward more efficient, connected, and clinically meaningful use of AI in medical imaging.

About PrediSurge

PrediSurge was founded to bring Predictive & Personalised medicine to cardiovascular care — where AI becomes a trusted surgical assistant, elevating precision, enhancing clinical confidence, and saving patients' lives.

After more than 17 years of research and clinical validation, PrediSurge’s AI solutions enable physicians to simulate patient-specific stent graft deployments preoperatively, assess complication risks such as endoleaks, and assist them in selecting the optimal intervention strategy for each patient.

With the latest product launch, physicians can now access a completely free MPR Viewer with case sharing capabilities, as well as iSizing, PrediSurge's tool for fully automated segmentation and sizing measurements in just a few clicks. Vascular experts can now visualise and adjust their intervention planning on interactive 3D model including thrombus and calcification.

*PlanOp iSizing V1 is a medical device software (class IIa, CE 0123) available in Europe and UK. As a manufacturer, PrediSurge provides more information with software output (Sizing report).

**ERI is a feature of PlanOp Aortic V2.2, a CE-marked medical device. Predisurge provides a complete simulation report that should be used together with iViewPro Viewer.

About Incepto

Incepto is a European leader in medical imaging AI. Through a single platform, Incepto curates best-in-class AI applications and connects them to hospital systems through its orchestration and interoperability technology, with continuous performance monitoring and no vendor lock-in. More than 450 medical centers across Europe and the US rely on Incepto, benefiting 6 million patients every year. Incepto's solutions are hosted on HDS-certified infrastructure within the European Union, in compliance with GDPR, ISO 13485 and ISO 27001.

ARVA medical device is a regulated health product that bears the CE mark, Class IIa. Notified Body: IMQ. N°0051. Manufacturer: Incepto Medical. ARVA is a diagnostic tool and shall not be used alone to recommend medical care for diagnostic purposes. Please read the instructions in the user manual carefully. Please contact contact@incepto-medical.com for more information.